Business

Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News

Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News.

articleMedical Marijuana, Inc.July 26, 20223/company/medical-marijuana-i/news/medical-marijuana-inc-ceo-provides-insight-on-future-of-us-cannabis-market-in-nasdaq-news
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News

About this update from Medical Marijuana, Inc.

[{"type":"text","content":"\n SAN DIEGO, CA, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its CEO Blake Schroeder has published an article in Nasdaq News to provide the industry with insight on the future of federal cannabis legalization in the U.S. In his article titled, “​​How Using the CBD Marketplace Can Set a Strong Stage for U.S. Cannabis”, Blake explains how the non-psychoactive hemp CBD market presents a unique opportunity to build a customer base and lay the groundwork for psychoactive tetrahydrocannabinol (THC) product sales once federally legal. He explains how the THC market, which is currently only legal on a state-by-state basis, can learn from the regulatory, testing, banking, legal, and other business related challenges that the CBD market overcame prior to the passing of the 2018 Farm Bill. He highlights how this can help businesses that aim to be in the THC space establish a strong foundation for a federally legal market and provide consumers with safe products.  Blake also highlights the importance of international product pipelines as they present unique opportunities and challenges to provide free access to cannabis products to people around the world and reach new and untapped markets that may loosen cannabis sales restrictions in the future. “I am very proud of the hard work our company has done to create a legitimate and legal non-psychoactive cannabis marketplace that we have today and am excited to see that replicated in the THC market once our federal legislation changes,” said Medical Marijuana, Inc. CEO Blake Schroeder. “We believe we are well-positioned in that space when it becomes federally legal.  We have global infrastructure that we will be able to leverage as laws change around the world for the better.” To learn more about the company, please visit https://www.medicalmarijuanainc.com/.  About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a glo...

More updates from Medical Marijuana, Inc.